|View printer-friendly version|
|September 14, 1999 10:33 a.m.|
|Teva Pharmaceutical Industries Ltd. Announces Completion Of Tender Offer For Copley Pharmaceutical, Inc.|
Jerusalem, Israel, September 14, 1999 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that its indirect wholly owned subsidiary Caribou Merger Corporation has accepted for payment approximately 18,900,000 shares of common stock of Copley Pharmaceutical, Inc. (Nasdaq: CPLY), representing approximately 93.8 % of the outstanding shares of Copley Pharmaceutical, Inc. (including approximately 550,000 tendered by means of guaranteed delivery), at $11.00 per share in cash in accordance with its tender offer for all outstanding shares of Copley Pharmaceutical, Inc. Approximately 1,250,000 shares of Copley Pharmaceutical, Inc. were not tendered and remain outstanding. The tender offer expired at 12:00 Midnight, New York City time on Monday, September 13, 1999.